Balance Sheet Data

Abbott Laboratories (ABT)

$119.4

+0.71 (+0.60%)

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Actual
2024
Projected
2025
Projected
2026
Projected
2027
Projected
2028
Projected
Total Cash 4,1407,14810,24910,1707,2798,449.889,002.599,591.4610,218.8410,887.25
Total Cash (%)
Account Receivables 5,4256,4146,4878,8816,5657,461.937,950.018,470.039,024.059,614.32
Account Receivables (%)
Inventories 4,3165,0125,1576,1736,5706,025.626,419.766,839.677,287.067,763.71
Inventories (%)
Accounts Payable 3,2523,9464,4084,6074,2954,537.374,834.175,150.375,487.265,846.18
Accounts Payable (%)
Capital Expenditure -1,638-2,177-1,885-1,777-2,202-2,167.52-2,309.30-2,460.35-2,621.28-2,792.74
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.